Jeffrey J. Ansley
Shareholder
300 Crescent Court, Suite 400 Dallas, Texas 75201
- jansley@vedderprice.com
- VCard
Jeffrey J. Ansley
Shareholder
Jeffrey J. Ansley is a Shareholder in Vedder Price’s Government Investigations & White Collar Defense group focused on white collar defense, representing professionals and corporate clients in criminal and regulatory investigations and in court when the time comes.
He has long been a white collar trial lawyer with an emphasis on health care fraud, anti-kickback allegations, securities fraud and other alleged business crimes. Mr. Ansley regularly represents individuals and companies in complex matters involving the Department of Justice (DOJ), the Securities and Exchange Commission (SEC), the Federal Bureau of Investigation (FBI), the Department of Health and Human Services Office of Inspector General (HHS-OIG), the Health Care Fraud Prevention and Enforcement Action Team (HEAT) and Health Care Fraud Strike Force, the Department of Defense (DOD) and many other government agencies.
Mr. Ansley is a Chambers USA-ranked, seasoned white collar criminal defense trial lawyer and former federal fraud prosecutor for the United States Attorney’s Office for the Northern District of Texas. He has successfully tried numerous federal criminal cases for and against the government, including as lead trial counsel in a month-long jury trial resulting in a complete defense verdict in an alleged $500 million health care fraud and kickback scheme. He focuses exclusively on white collar criminal defense, federal trials and grand jury matters, internal investigations, and regulatory and enforcement actions. He routinely handles cases involving the False Claims Act (FCA) and parallel criminal investigations; the Anti-Kickback Statute (AKS); Stark I and II; health care fraud; the Foreign Corrupt Practices Act (FCPA); allegations of fraud involving financial institutions and their personnel; securities and other financial fraud, insider trading, bribery and public corruption, government contractor fraud; import and export controls; tax fraud; antitrust; money laundering; obstruction of justice; extortion; and mail, wire and honest services fraud. Mr. Ansley’s practice routinely positions him between his clients and the government.
In the health care industry, he defends physicians and other health care providers, practice groups, hospitals, dentists, DSOs, pharmacists and marketers in criminal and regulatory investigations, prosecutions and trials. In the securities industry, he represents public companies, their officers and directors, broker-dealers, financial advisers and advisory firms, and other securities industry participants in investigations and proceedings by the DOJ, SEC, Financial Industry Regulatory Authority (FINRA) and state securities regulators.
Mr. Ansley also has led numerous internal investigations into possible criminal and regulatory misconduct and counsels clients regarding compliance in these areas.
Before joining Vedder Price, Mr. Ansley served for almost a decade as an Assistant U.S. Attorney in the Major Fraud and Public Corruption Section of the U.S. Attorney’s Office for the Northern District of Texas. As an AUSA, he led the district’s inter-agency Fraud Task Force, where he prosecuted and tried complex health care fraud, securities fraud and public corruption cases. Notably, he was lead counsel in the investigation, prosecution and eventual months’-long trial of the largest Ponzi scheme in the Northern District of Texas, culminating in guilty verdicts and extensive sentences for the architects of the fraud.
Based on his combined experience as a fraud prosecutor and SEC attorney, Mr. Ansley has an insider’s knowledge of the tactics used by prosecutors and investigators, resources he now uses on behalf of his clients. This experience makes him uniquely qualified to handle not only these investigations and charges, but also any collateral regulatory, administrative and civil consequences.
Mr. Ansley is ranked by Chambers USA for “Litigation: White-Collar Crime & Government Investigations,” Texas – Band 2, where he is described as “a go-to for white-collar matters,” “very, very well versed in healthcare fraud investigations and defense” and “the consummate client-focused attorney.” He has been selected by his peers for inclusion in The Best Lawyers in America® since 2018, was named a “Litigation Star” in the Benchmark Litigation 2020 guide and has been selected by his peers for inclusion in Thompson Reuters Super Lawyers since 2010. The Legal 500 United States recommended Mr. Ansley in the Dispute Resolution: Corporate Investigations and White-Collar Criminal Defense category in 2024. He is consistently recognized by Texas Monthly and D Magazine as a top practitioner and for the strength of his white collar defense practice and serves as a frequent speaker, author and commentator.
Jeffrey J. Ansley
Shareholder
Education
- SMU Dedman School of Law, J.D., 1994
- Texas A&M University, B.A., 1991, cum laude
Jeffrey J. Ansley
Shareholder
Bar Admissions
- Texas, 1994
Court Admissions
- U.S. District Court, Eastern District of Texas, 2008
- U.S. District Court, Northern District of Texas, 1994
- U.S. District Court, Southern District of Texas, 2008
- U.S. District Court, Western District of Texas, 2008
- U.S. District Court, Southern District of Mississippi, 2020
- U.S. Court of Appeals, Fifth Circuit, 2009
Affiliations
- Fellow, Texas Bar Foundation
- Member, Federal Bar Association
- Member, American Bar Association, White Collar Section
- Member, Dallas Bar Association, Criminal Law and Securities Law Sections
- Member, American Health Lawyers Association
Jeffrey J. Ansley
Shareholder
-
Publications
-
February 16, 2023 | Article
-
July 18, 2022 | Publication
-
May 27, 2022 | Newsletter/Bulletin
-
September 2, 2022 | PublicationWill PPP Fraud Turn into the Next Wave of 'Liar's Loans'? Accounting Today
-
June, 2020 | PublicationHow Federal and State Workers May Impact Care in Texas D Magazine
-
July, 2018 | PublicationThe Criminal Regulatory Framework Health Care Compliance Association (HCCA) Compliance Today
-
August, 2015 | PublicationThe Anatomy of an SEC Investigation eb5 Investors, Vol. 2, Issue No. 3
-
March, 2014 | PublicationThe Ends Do Not Justify the Means: Pre-Trial Asset Freezes Increasingly Paralyze the Defense The Texas Lawbook
-
May, 2013 | PublicationFacebook, You and the Government: The SEC Is Following Your Tweets The Texas Lawbook
-
December, 2011 | PublicationWhere Did My Privilege Go? Congress and Its Discretion to Ignore the Attorney-Client Privilege Criminal Law Bulletin
-
October, 2011 | PublicationRisks and Mistakes Come with the Territory: The Difficult Task of the SEC The Texas Lawbook
Jeffrey J. Ansley
Shareholder
-
News
-
August 21, 2024 | Media Mention
-
August 21, 2024 | Press Release
-
August 15, 2024 | Press Release
-
June 12, 2024 | Press Release
-
June 6, 2024 | Press Release
-
April 25, 2024 | Media Mention
-
August 17, 2023 | Press Release
-
June 1, 2023 | Press Release
-
April 27, 2023 | Press Release
-
August 18, 2022 | Press Release
-
June 1, 2022 | Press Release
-
February 10, 2022 | Press Release
-
Jeffrey J. Ansley
Shareholder
Experience
*Includes in some cases Mr. Ansley’s previous experience
- Successfully defended a physician accused of conspiring to submit millions of dollars in false claims for medical services to numerous insurers, securing a complete defense verdict and acquittal following a complex federal jury trial in the Eastern District of Texas
- Successfully defended pharmacist accused of conspiracy to commit health care fraud and violation of the Anti-Kickback Statute in multi-week federal jury trial
- Successfully defended trader against insider trading securities fraud charges in federal jury trial
- Successfully tried multiple federal jury trials involving charges of securities fraud, health care fraud, public corruption, bank fraud, wire and mail fraud, tax fraud, money laundering and conspiracy
- Successfully defended client in complex federal health care fraud trial based on alleged Anti-Kickback Statute violations, ending in mistrial after six weeks based on government misconduct shown by our defense
- Successfully secured pretrial diversion agreements on behalf of health care, securities, and other industry professionals accused of health care fraud and violations of the Anti-Kickback Statutes, Computer Fraud and Abuse Act, Economic Espionage Act, and similar complex federal crimes
- Routinely defending physicians, dentists, pharmacists, marketers, lab owners and related individuals in health care fraud investigations and prosecutions
- Routinely defending corporate officers, directors and other management in securities fraud investigations and prosecutions
- Successfully defended health care staffing company and its senior personnel in federal False Claims Act investigation and preempted DOJ intervention
- Successfully defended recipient company of federal educational grant funds in federal False Claims Act investigation and preempted DOJ intervention
- Conducted numerous internal investigations involving allegations of securities fraud, fund misappropriation, accounting fraud and other improper accounting practices, health care fraud and violations of the False Claims Act, Anti-Kickback Statute and Stark Law, among other complex statutes and regulations
- Defended physician charged with health care fraud and conspiracy involving a hospice facility
- Defended corporate officer charged with securities fraud, wire fraud and conspiracy
- Successfully defended dentist and DSO owner in federal Anti-Kickback Statute case
- Conducted internal investigation on behalf of corporation regarding allegations of embezzlement and misappropriation of funds by a senior executive
- Successfully defended bank against charges by the FDIC of improper lending practices
- Represented health care executive in a federal sentencing in connection with money laundering, health care fraud and corruption charges
- Represented and obtained below-Guidelines sentences for physicians, securities professionals, securities traders and others against federal charges
- Successfully defended and secured closure of investigations by the DOJ and SEC relating to suspected insider trading
- Defended senior executive in federal jury trial charged with conspiracy and securities fraud in connection with complex real estate offerings